CELL AND GENE THERAPY INSIGHTS

New horizons in cellular immunotherapy

August 2022
New horizons in cellular immunotherapy

Expert Roundtable

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Autologous versus allogeneic: the future of manufacturing and standardization in cell therapies

Rupa Pike, Delara Motlagh, Patrick Hanley
5 October 2022
Read

FastFacts

Scalable production of lipid nanoparticles for effective gene delivery

Scalable production of lipid nanoparticles for effective gene delivery

Reka Geczy
12 October 2022
Read

Podcast

Working together to safely advance cell & gene therapies

Working together to safely advance cell & gene therapies

J Maher, A J King, F Neethling et al.
12 September 2022
Listen

Viewpoint

In vivo engineering of CAR T cell therapies

In vivo engineering of CAR T cell therapies

Haig Aghajanian
30 August 2022
Read
A journey in synthetic biology: using gene circuit technology in immuno-oncology

A journey in synthetic biology: using gene circuit technology in immuno-oncology

Timothy Lu, James Collins
25 August 2022
Read
The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

The power of combining iPSC-derived NK cell therapy & NK-cell engager antibodies

Dr Wei Li, Dr Daniel Teper
22 July 2022
Read

Interview

Advancing genome edited allogeneic cell therapies into the clinic

Advancing genome edited allogeneic cell therapies into the clinic

Steve Kanner
26 August 2022
Read
Ensuring commercial readiness in the cellular cancer immunotherapy space

Ensuring commercial readiness in the cellular cancer immunotherapy space

Julian Adams, Michele Korfin, Ronit Simantov
16 August 2022
Read